Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qingxin Huatan therapy plus conventional western treatment for stable coronary heart disease angina with phlegm-heat syndrome
ChiCTR-TRC-14004699Phase 4Not yet recruiting
- Sponsor
- Third Affiliated Hospital, Beijing University of Chinese Medicine
- Start
- Dec 2013
- Countries
- 1
01
Overview
Phase 4, randomised trial of Lianxia Ningxin Granules in coronary arteriosclerosis and angina pectoris (2 arms), sponsored by Third Affiliated Hospital, Beijing University of Chinese Medicine. Primary endpoints: heart rhythm, blood pressure and 8 more. Planned start Dec 2013; status: not yet recruiting.
02
Drugs
Lianxia Ningxin Granules
03
Conditions
coronary arteriosclerosisangina pectoris
Beyond the preview
Go deeper on ChiCTR-TRC-14004699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004699.